Search Within

Head and Neck Service

Formats
  1. Journal Article (412)
  2. Meeting Abstract (361)
  3. Book Section (21)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Solid Tumor Oncology Division (841)
  2. Department of Medicine (835)
  3. Surgery (363)
  4. Head and Neck Surgery (342)
  5. Radiation Oncology, Department of (314)
  6. Survivorship Research (312)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (346)
  3. Nancy Lee (270)
  4. Alan Ho (243)
  5. Nadeem Riaz (163)
  6. Richard Wong (143)

More People

Years
  1. 2025 (19)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (67)

More Years

Publications
  1. Journal of Clinical Oncology (208)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (29)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (222)
  2. Elsevier Inc. (176)
  3. Oxford University Press (55)
  4. Wiley Blackwell (54)
  5. American Association for Cancer Research (46)
  6. John Wiley & Sons, Inc. (29)

More Publishers

Results (841)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trends in chronic opioid therapy among survivors of head and neck cancer
    Journal Article

    Kriplani, A.; Lavery, J. A.; Mishra, A.; Korenstein, D.; Lipitz-Snyderman, A. N.; Boudreau, D. M.; Moryl, N.; Gillespie, E. F.; Salz, T.
    Head & Neck (2021)

    Fulltext@MSK | Save
  • Secondary lung cancer
    Book Section

    Lacayo, E. A.; Solomon, S.; Ho, A.
    In Georgiades, C.; Kim, H. S. (Eds.) Image-Guided Interventions in Oncology: An Interdisciplinary Approach (2020)

    Fulltext@MSK | Save
  • TROPiCS-03: A phase II open-label study of sacituzumab govitecan (SG) in patients with metastatic solid tumors
    Meeting Abstract

    Saxena, A.; Michel, L. S.; Hong, Q.; Hilsinger, K.; Kanwal, C.; Pichardo, C.; Goswami, T.; Santin, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent or metastatic adenoid cystic carcinoma
    Meeting Abstract

    Kang, H.; Ho, A. L.; Muzaffar, J.; Bowles, D. W.; Kim, S. B.; Ahn, M. J.; Hanna, G. J.; Worden, F. P.; Yun, T.; Norton, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The AIM-HN and SEQ-HN study: A pivotal study evaluating the efficacy of tipifarnib in patients with head and neck squamous cell carcinoma (HNSCC) with HRAS mutations (AIM-HN) and the impact of HRAS mutations on response to first line systemic therapies for HNSCC (SEQ-HN)
    Meeting Abstract

    Haddad, R. I.; Harrington, K. J.; Licitra, L. F.; Psyrri, A.; Saba, N. F.; Rajicic, N.; Balsara, B.; Kurman, M. R.; Scholz, C. R.; Gualberto, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16(+) cancers
    Meeting Abstract

    Burman, B.; Niu, J.; Leidner, R. S.; Wang, D.; Richardson, D. L.; Iacobucci, C.; Hwang, A.; Qing, X.; Matushansky, I.; Zamarin, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Interim analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (MBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIS)
    Meeting Abstract

    Lewis, K.; Peris, K.; Sekulic, A.; Stratigos, A.; Dunn, L.; Eroglu, Z.; Chang, A. L.; Migden, M.; Li, S.; Mohan, K.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer
    Meeting Abstract

    Pai, S.; Adkins, D.; Wirth, L.; Chung, C.; Gibson, M.; Sukari, A.; Worden, F.; Colevas, D.; Saba, N.; Burtness, B.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (MTC)
    Meeting Abstract

    Shah, M.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Leboulleux, S.; Godbert, Y.; more...
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Split high-dose cisplatin: An alternate high-dose cisplatin administration schedule for definitive chemoradiation in oropharyngeal cancer
    Meeting Abstract

    Kang, J. J.; Tchekmedyian, V.; Fan, M.; Wang, H.; Kitpanit, S.; Mohamed, N.; Rybkin, A.; Lee, A.; Chen, L.; Yu, Y.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save